Genetic Association of Epilepsy and Anti-Epileptic Drugs Treatment in Jordanian Patients
Open Access
- 1 October 2020
- journal article
- research article
- Published by Taylor & Francis in Pharmacogenomics and Personalized Medicine
- Vol. ume 13, 503-510
Abstract
Purpose: The aim of this study was to investigate the possible effects of single-nucleotide polymorphisms (SNPs) within SLC1A1, SLC6A1, FAM131B, GPLD1, F2, GABRG2, GABRA1, and CACNG5 genes on response to anti-epileptic drugs (AEDs) and the genetic predisposition of epilepsy in Jordanian patients. Patients and Methods: A total of 299 healthy individuals and 296 pediatric patients from the Jordanian population were recruited. Blood samples are collected, and genotyping was performed using a custom platform array analysis. Results: The SLC1A1 rs10815018 and FAM131B rs4236482 polymorphisms found to be associated with epilepsy susceptibility. Moreover, SLC1A1 rs10815018 and GPLD1 rs1126617 polymorphisms were associated with generalized epilepsy (GE), while FAM131B rs4236482 is associated with the focal phenotype. Regarding the therapeutic response, the genetic polymorphisms of FAM131B rs4236482, GABRA1 rs2279020, and CACNG5 rs740805 are conferred poor response (resistance) to AEDs. There was no linkage of GLPD1 haplotypes to epilepsy, its subtypes, and treatment responsiveness. Conclusion: Our findings suggested that SLC1A1, FAM131B, and GPLD1 polymorphisms increasing the risk of generating epilepsy, while FAM131B, GABRA1, and CACNG5 variants may play a role in predicting drug response in patients with epilepsy (PWE).Keywords
This publication has 49 references indexed in Scilit:
- K+ channelepsy: progress in the neurobiology of potassium channels and epilepsyFrontiers in Cellular Neuroscience, 2013
- Major channels involved in neuropsychiatric disorders and therapeutic perspectivesFrontiers in Genetics, 2013
- Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatmentThe World Journal of Biological Psychiatry, 2012
- Comprehensive family‐based association study of the glutamate transporter gene SLC1A1 in obsessive‐compulsive disorderAmerican Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2011
- Case–case genome-wide association analysis shows markers differentially associated with schizophrenia and bipolar disorder and implicates calcium channel genesPsychiatric Genetics, 2011
- Rare Deletions at 16p13.11 Predispose to a Diverse Spectrum of Sporadic Epilepsy SyndromesThe American Journal of Human Genetics, 2010
- Genetics of early-onset obsessive–compulsive disorderEuropean Child & Adolescent Psychiatry, 2010
- The descriptive epidemiology of epilepsy—A reviewEpilepsy Research, 2009
- The GABA transporter 1 (SLC6A1): a novel candidate gene for anxiety disordersJournal of Neural Transmission, 2008
- Thrombin Induces Long-Term Potentiation of Reactivity to Afferent Stimulation and Facilitates Epileptic Seizures in Rat Hippocampal Slices: Toward Understanding the Functional Consequences of Cerebrovascular InsultsJournal of Neuroscience, 2008